prikaz prve stranice dokumenta Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report
  Preuzmi
PDF 494.73 KB
Znanstveni rad - Prikaz slučaja
Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report
Croatian Medical Journal, 60 (2019), 6; 552-555. https://doi.org/10.3325/cmj.2019.60.552
Rkman, Deni; Likić, Robert; Bebek, Marko; Gnjidić, Milena; Gamulin, Marija

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Rkman, D., Likić, R., Bebek, M., Gnjidić, M. i Gamulin, M. (2019). Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report. Croatian Medical Journal, 60. (6), 552-555. doi: 10.3325/cmj.2019.60.552

Rkman, Deni, et al. "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report." Croatian Medical Journal, vol. 60, br. 6, 2019, str. 552-555. https://doi.org/10.3325/cmj.2019.60.552

Rkman, Deni, Robert Likić, Marko Bebek, Milena Gnjidić i Marija Gamulin. "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report." Croatian Medical Journal 60, br. 6 (2019): 552-555. https://doi.org/10.3325/cmj.2019.60.552

Rkman, D., et al. (2019) 'Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report', Croatian Medical Journal, 60(6), str. 552-555. doi: 10.3325/cmj.2019.60.552

Rkman D, Likić R, Bebek M, Gnjidić M, Gamulin M. Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report. Croatian Medical Journal [Internet]. 2019. [pristupljeno 22.11.2024.];60(6):552-555. doi: 10.3325/cmj.2019.60.552

D. Rkman, R. Likić, M. Bebek, M. Gnjidić i M. Gamulin, "Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report", Croatian Medical Journal, vol. 60, br. 6, str. 552-555, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:676034. [Citirano: 22.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:676034
Podaci o radu
Naslov (engleski)Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report
AutorDeni Rkman
AutorRobert Likić
AutorMarko Bebek
AutorMilena Gnjidić
AutorMarija Gamulin
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Jezikengleski
Vrsta publikacijeZnanstveni rad - Prikaz slučaja
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCroatian Medical Journal
Brojčani podacivol. 60, br. 6, str. 552-555
p-ISSN0353-9504
DOIhttps://doi.org/10.3325/cmj.2019.60.552
URN:NBNurn:nbn:hr:105:676034
Datum objave publikacije2019
URL dokumentahttp://doi.org/10.3325/cmj.2019.60.552
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:34:06